Verastem reported $-0.44 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Alaunos Therapeutics USD -0.39 0.12 Jun/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Curis USD -11.82 13.04 Mar/2026
Cytokinetics USD -1.37 0.13 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
Laboratory Of America USD 4.78 0.21 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
TG Therapeutics USD 0.05 0.07 Jun/2026
Verastem USD -0.44 0.04 Mar/2026